Protective Effects of Natural Non‐insulin Drugs against Type 1 Diabetes Mellitus Article Swipe
Waseem Hassan
,
FarazaJavaid
,
Andleeb Shahzadiand
,
Sahar Bakht
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1002/9781119983347.ch10
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1002/9781119983347.ch10
Type 1 diabetes mellitus (T1DM), often known as autoimmune diabetes, affects 10 million people around the world. This condition is characterized by the death of pancreatic cells by autoimmunity, resulting in insulin insufficiency, hyperglycemia, and complications. The only treatment option is insulin injection, but it comes with a slew of significant side effects. Immunotherapy, replacement therapy, and combination therapy are all now used to treat T1DM. Despite recent advancements in anti-diabetic therapies, none of these options has proven to be clinically effective. Plants and their secondary metabolites are a fantastic source of natural medications for a variety of ailments. Natural products and their derivatives have been used to generate 50% of prescription medications in the last 25 years. We attempt to offer a scientific viewpoint on the application of traditional natural medications for the treatment of diabetes.
Related Topics
Concepts
Metadata
- Type
- other
- Language
- en
- Landing Page
- https://doi.org/10.1002/9781119983347.ch10
- https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/9781119983347.ch10
- OA Status
- gold
- References
- 64
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4385562890
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4385562890Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1002/9781119983347.ch10Digital Object Identifier
- Title
-
Protective Effects of Natural Non‐insulin Drugs against Type 1 Diabetes MellitusWork title
- Type
-
otherOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-07-22Full publication date if available
- Authors
-
Waseem Hassan, FarazaJavaid, Andleeb Shahzadiand, Sahar BakhtList of authors in order
- Landing page
-
https://doi.org/10.1002/9781119983347.ch10Publisher landing page
- PDF URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/9781119983347.ch10Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/9781119983347.ch10Direct OA link when available
- Concepts
-
Medicine, Type 1 diabetes, Insulin, Diabetes mellitus, Medical prescription, Intensive care medicine, Immunotherapy, Autoimmunity, Type 2 diabetes, Type 2 Diabetes Mellitus, Pharmacology, Internal medicine, Endocrinology, Disease, CancerTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
64Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4385562890 |
|---|---|
| doi | https://doi.org/10.1002/9781119983347.ch10 |
| ids.doi | https://doi.org/10.1002/9781119983347.ch10 |
| ids.openalex | https://openalex.org/W4385562890 |
| fwci | |
| type | other |
| title | Protective Effects of Natural Non‐insulin Drugs against Type 1 Diabetes Mellitus |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | 176 |
| biblio.first_page | 164 |
| topics[0].id | https://openalex.org/T11140 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9976999759674072 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2712 |
| topics[0].subfield.display_name | Endocrinology, Diabetes and Metabolism |
| topics[0].display_name | Natural Antidiabetic Agents Studies |
| topics[1].id | https://openalex.org/T12964 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9782999753952026 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2712 |
| topics[1].subfield.display_name | Endocrinology, Diabetes and Metabolism |
| topics[1].display_name | Diet, Metabolism, and Disease |
| topics[2].id | https://openalex.org/T14478 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9739999771118164 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2707 |
| topics[2].subfield.display_name | Complementary and alternative medicine |
| topics[2].display_name | Papaya Research and Applications |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.8271948099136353 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2781232474 |
| concepts[1].level | 3 |
| concepts[1].score | 0.6687909364700317 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q124407 |
| concepts[1].display_name | Type 1 diabetes |
| concepts[2].id | https://openalex.org/C2779306644 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6232143044471741 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q2002370 |
| concepts[2].display_name | Insulin |
| concepts[3].id | https://openalex.org/C555293320 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6211812496185303 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q12206 |
| concepts[3].display_name | Diabetes mellitus |
| concepts[4].id | https://openalex.org/C2426938 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5381126999855042 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q3355478 |
| concepts[4].display_name | Medical prescription |
| concepts[5].id | https://openalex.org/C177713679 |
| concepts[5].level | 1 |
| concepts[5].score | 0.5189363956451416 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q679690 |
| concepts[5].display_name | Intensive care medicine |
| concepts[6].id | https://openalex.org/C2777701055 |
| concepts[6].level | 3 |
| concepts[6].score | 0.48317041993141174 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q1427096 |
| concepts[6].display_name | Immunotherapy |
| concepts[7].id | https://openalex.org/C2780130043 |
| concepts[7].level | 3 |
| concepts[7].score | 0.46889370679855347 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q192360 |
| concepts[7].display_name | Autoimmunity |
| concepts[8].id | https://openalex.org/C2777180221 |
| concepts[8].level | 3 |
| concepts[8].score | 0.447787344455719 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q3025883 |
| concepts[8].display_name | Type 2 diabetes |
| concepts[9].id | https://openalex.org/C2910068830 |
| concepts[9].level | 3 |
| concepts[9].score | 0.4377892315387726 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q3025883 |
| concepts[9].display_name | Type 2 Diabetes Mellitus |
| concepts[10].id | https://openalex.org/C98274493 |
| concepts[10].level | 1 |
| concepts[10].score | 0.3099328875541687 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[10].display_name | Pharmacology |
| concepts[11].id | https://openalex.org/C126322002 |
| concepts[11].level | 1 |
| concepts[11].score | 0.2838283181190491 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[11].display_name | Internal medicine |
| concepts[12].id | https://openalex.org/C134018914 |
| concepts[12].level | 1 |
| concepts[12].score | 0.21391117572784424 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q162606 |
| concepts[12].display_name | Endocrinology |
| concepts[13].id | https://openalex.org/C2779134260 |
| concepts[13].level | 2 |
| concepts[13].score | 0.18538731336593628 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[13].display_name | Disease |
| concepts[14].id | https://openalex.org/C121608353 |
| concepts[14].level | 2 |
| concepts[14].score | 0.08732345700263977 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[14].display_name | Cancer |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.8271948099136353 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/type-1-diabetes |
| keywords[1].score | 0.6687909364700317 |
| keywords[1].display_name | Type 1 diabetes |
| keywords[2].id | https://openalex.org/keywords/insulin |
| keywords[2].score | 0.6232143044471741 |
| keywords[2].display_name | Insulin |
| keywords[3].id | https://openalex.org/keywords/diabetes-mellitus |
| keywords[3].score | 0.6211812496185303 |
| keywords[3].display_name | Diabetes mellitus |
| keywords[4].id | https://openalex.org/keywords/medical-prescription |
| keywords[4].score | 0.5381126999855042 |
| keywords[4].display_name | Medical prescription |
| keywords[5].id | https://openalex.org/keywords/intensive-care-medicine |
| keywords[5].score | 0.5189363956451416 |
| keywords[5].display_name | Intensive care medicine |
| keywords[6].id | https://openalex.org/keywords/immunotherapy |
| keywords[6].score | 0.48317041993141174 |
| keywords[6].display_name | Immunotherapy |
| keywords[7].id | https://openalex.org/keywords/autoimmunity |
| keywords[7].score | 0.46889370679855347 |
| keywords[7].display_name | Autoimmunity |
| keywords[8].id | https://openalex.org/keywords/type-2-diabetes |
| keywords[8].score | 0.447787344455719 |
| keywords[8].display_name | Type 2 diabetes |
| keywords[9].id | https://openalex.org/keywords/type-2-diabetes-mellitus |
| keywords[9].score | 0.4377892315387726 |
| keywords[9].display_name | Type 2 Diabetes Mellitus |
| keywords[10].id | https://openalex.org/keywords/pharmacology |
| keywords[10].score | 0.3099328875541687 |
| keywords[10].display_name | Pharmacology |
| keywords[11].id | https://openalex.org/keywords/internal-medicine |
| keywords[11].score | 0.2838283181190491 |
| keywords[11].display_name | Internal medicine |
| keywords[12].id | https://openalex.org/keywords/endocrinology |
| keywords[12].score | 0.21391117572784424 |
| keywords[12].display_name | Endocrinology |
| keywords[13].id | https://openalex.org/keywords/disease |
| keywords[13].score | 0.18538731336593628 |
| keywords[13].display_name | Disease |
| keywords[14].id | https://openalex.org/keywords/cancer |
| keywords[14].score | 0.08732345700263977 |
| keywords[14].display_name | Cancer |
| language | en |
| locations[0].id | doi:10.1002/9781119983347.ch10 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | |
| locations[0].pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/9781119983347.ch10 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | other |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Natural Products and their Bioactives in Antidiabetic Drug Discovery |
| locations[0].landing_page_url | https://doi.org/10.1002/9781119983347.ch10 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5044324691 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-0197-1736 |
| authorships[0].author.display_name | Waseem Hassan |
| authorships[0].countries | PK |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I16076960 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Pharmacy, COMSATS University Islamabad, Lahore Campus, Lahore, 54000 Pakistan |
| authorships[0].institutions[0].id | https://openalex.org/I16076960 |
| authorships[0].institutions[0].ror | https://ror.org/00nqqvk19 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I16076960 |
| authorships[0].institutions[0].country_code | PK |
| authorships[0].institutions[0].display_name | COMSATS University Islamabad |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Waseem Hassan,, |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Department of Pharmacy, COMSATS University Islamabad, Lahore Campus, Lahore, 54000 Pakistan |
| authorships[1].author.id | https://openalex.org/A5092595133 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | FarazaJavaid |
| authorships[1].countries | PK |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I12469534 |
| authorships[1].affiliations[0].raw_affiliation_string | Quaid-e-Azam College of Pharmacy, Sahiwal, Pakistan |
| authorships[1].institutions[0].id | https://openalex.org/I12469534 |
| authorships[1].institutions[0].ror | https://ror.org/04s9hft57 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I12469534 |
| authorships[1].institutions[0].country_code | PK |
| authorships[1].institutions[0].display_name | Quaid-i-Azam University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | FarazaJavaid , |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Quaid-e-Azam College of Pharmacy, Sahiwal, Pakistan |
| authorships[2].author.id | https://openalex.org/A5092595134 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Andleeb Shahzadiand |
| authorships[2].countries | TR |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210112471 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Medical Pharmacology, Cerrahpaşa Medical Faculty, Istanbul University-Cerrahpaşa, Istanbul, Turkey |
| authorships[2].institutions[0].id | https://openalex.org/I4210112471 |
| authorships[2].institutions[0].ror | https://ror.org/01dzn5f42 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210112471 |
| authorships[2].institutions[0].country_code | TR |
| authorships[2].institutions[0].display_name | Istanbul University-Cerrahpaşa |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Andleeb Shahzadiand |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Medical Pharmacology, Cerrahpaşa Medical Faculty, Istanbul University-Cerrahpaşa, Istanbul, Turkey |
| authorships[3].author.id | https://openalex.org/A5041477915 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-1158-8474 |
| authorships[3].author.display_name | Sahar Bakht |
| authorships[3].countries | PK |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I194348271 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Pharmaceutical Chemistry, Government College University Faisalabad, Faisalabad, Pakistan |
| authorships[3].institutions[0].id | https://openalex.org/I194348271 |
| authorships[3].institutions[0].ror | https://ror.org/051zgra59 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I194348271 |
| authorships[3].institutions[0].country_code | PK |
| authorships[3].institutions[0].display_name | Government College University, Faisalabad |
| authorships[3].author_position | last |
| authorships[3].raw_author_name | Sahar Bakht |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Pharmaceutical Chemistry, Government College University Faisalabad, Faisalabad, Pakistan |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/9781119983347.ch10 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Protective Effects of Natural Non‐insulin Drugs against Type 1 Diabetes Mellitus |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11140 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9976999759674072 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2712 |
| primary_topic.subfield.display_name | Endocrinology, Diabetes and Metabolism |
| primary_topic.display_name | Natural Antidiabetic Agents Studies |
| related_works | https://openalex.org/W2361820086, https://openalex.org/W4388487825, https://openalex.org/W2368224867, https://openalex.org/W3029903131, https://openalex.org/W3111030087, https://openalex.org/W2341334583, https://openalex.org/W2385685139, https://openalex.org/W1831490185, https://openalex.org/W3213488669, https://openalex.org/W2035967193 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1002/9781119983347.ch10 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/9781119983347.ch10 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | other |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Natural Products and their Bioactives in Antidiabetic Drug Discovery |
| best_oa_location.landing_page_url | https://doi.org/10.1002/9781119983347.ch10 |
| primary_location.id | doi:10.1002/9781119983347.ch10 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | |
| primary_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/9781119983347.ch10 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | other |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Natural Products and their Bioactives in Antidiabetic Drug Discovery |
| primary_location.landing_page_url | https://doi.org/10.1002/9781119983347.ch10 |
| publication_date | 2023-07-22 |
| publication_year | 2023 |
| referenced_works | https://openalex.org/W2134489063, https://openalex.org/W3003958661, https://openalex.org/W3084547526, https://openalex.org/W3040657106, https://openalex.org/W2994810741, https://openalex.org/W3090263156, https://openalex.org/W3103861847, https://openalex.org/W1757921042, https://openalex.org/W3130333914, https://openalex.org/W2030660601, https://openalex.org/W2777382514, https://openalex.org/W3155916271, https://openalex.org/W3198370926, https://openalex.org/W1996673479, https://openalex.org/W2095326585, https://openalex.org/W2161030469, https://openalex.org/W2187592799, https://openalex.org/W4282017367, https://openalex.org/W2079881257, https://openalex.org/W3000504327, https://openalex.org/W2404547241, https://openalex.org/W3011437930, https://openalex.org/W3174394869, https://openalex.org/W1973174042, https://openalex.org/W2029486574, https://openalex.org/W2980861748, https://openalex.org/W2962076438, https://openalex.org/W2071298657, https://openalex.org/W2761721016, https://openalex.org/W2616438587, https://openalex.org/W2903006485, https://openalex.org/W3097563363, https://openalex.org/W2226470635, https://openalex.org/W2024052292, https://openalex.org/W2990531953, https://openalex.org/W1964799799, https://openalex.org/W3093539241, https://openalex.org/W2153587608, https://openalex.org/W2101870447, https://openalex.org/W3175062399, https://openalex.org/W3193652841, https://openalex.org/W1142305748, https://openalex.org/W3198927183, https://openalex.org/W2092963185, https://openalex.org/W3163329426, https://openalex.org/W3196561475, https://openalex.org/W2996866943, https://openalex.org/W3204881076, https://openalex.org/W3107062700, https://openalex.org/W4200465983, https://openalex.org/W3184249653, https://openalex.org/W3217302746, https://openalex.org/W3128718666, https://openalex.org/W2020627089, https://openalex.org/W3176855609, https://openalex.org/W3095247844, https://openalex.org/W1608323437, https://openalex.org/W3154076471, https://openalex.org/W3025497789, https://openalex.org/W3159217912, https://openalex.org/W2156283489, https://openalex.org/W4213144883, https://openalex.org/W4280598815, https://openalex.org/W3095864827 |
| referenced_works_count | 64 |
| abstract_inverted_index.1 | 1 |
| abstract_inverted_index.a | 47, 88, 95, 122 |
| abstract_inverted_index.10 | 11 |
| abstract_inverted_index.25 | 116 |
| abstract_inverted_index.We | 118 |
| abstract_inverted_index.as | 7 |
| abstract_inverted_index.be | 79 |
| abstract_inverted_index.by | 21, 27 |
| abstract_inverted_index.in | 30, 69, 113 |
| abstract_inverted_index.is | 19, 40 |
| abstract_inverted_index.it | 44 |
| abstract_inverted_index.of | 24, 49, 73, 91, 97, 110, 128, 135 |
| abstract_inverted_index.on | 125 |
| abstract_inverted_index.to | 63, 78, 107, 120 |
| abstract_inverted_index.50% | 109 |
| abstract_inverted_index.The | 36 |
| abstract_inverted_index.all | 60 |
| abstract_inverted_index.and | 34, 56, 83, 101 |
| abstract_inverted_index.are | 59, 87 |
| abstract_inverted_index.but | 43 |
| abstract_inverted_index.for | 94, 132 |
| abstract_inverted_index.has | 76 |
| abstract_inverted_index.now | 61 |
| abstract_inverted_index.the | 15, 22, 114, 126, 133 |
| abstract_inverted_index.This | 17 |
| abstract_inverted_index.Type | 0 |
| abstract_inverted_index.been | 105 |
| abstract_inverted_index.have | 104 |
| abstract_inverted_index.last | 115 |
| abstract_inverted_index.none | 72 |
| abstract_inverted_index.only | 37 |
| abstract_inverted_index.side | 51 |
| abstract_inverted_index.slew | 48 |
| abstract_inverted_index.used | 62, 106 |
| abstract_inverted_index.with | 46 |
| abstract_inverted_index.T1DM. | 65 |
| abstract_inverted_index.cells | 26 |
| abstract_inverted_index.comes | 45 |
| abstract_inverted_index.death | 23 |
| abstract_inverted_index.known | 6 |
| abstract_inverted_index.offer | 121 |
| abstract_inverted_index.often | 5 |
| abstract_inverted_index.their | 84, 102 |
| abstract_inverted_index.these | 74 |
| abstract_inverted_index.treat | 64 |
| abstract_inverted_index.Plants | 82 |
| abstract_inverted_index.around | 14 |
| abstract_inverted_index.option | 39 |
| abstract_inverted_index.people | 13 |
| abstract_inverted_index.proven | 77 |
| abstract_inverted_index.recent | 67 |
| abstract_inverted_index.source | 90 |
| abstract_inverted_index.world. | 16 |
| abstract_inverted_index.years. | 117 |
| abstract_inverted_index.(T1DM), | 4 |
| abstract_inverted_index.Despite | 66 |
| abstract_inverted_index.Natural | 99 |
| abstract_inverted_index.affects | 10 |
| abstract_inverted_index.attempt | 119 |
| abstract_inverted_index.insulin | 31, 41 |
| abstract_inverted_index.million | 12 |
| abstract_inverted_index.natural | 92, 130 |
| abstract_inverted_index.options | 75 |
| abstract_inverted_index.therapy | 58 |
| abstract_inverted_index.variety | 96 |
| abstract_inverted_index.diabetes | 2 |
| abstract_inverted_index.effects. | 52 |
| abstract_inverted_index.generate | 108 |
| abstract_inverted_index.mellitus | 3 |
| abstract_inverted_index.products | 100 |
| abstract_inverted_index.therapy, | 55 |
| abstract_inverted_index.ailments. | 98 |
| abstract_inverted_index.condition | 18 |
| abstract_inverted_index.diabetes, | 9 |
| abstract_inverted_index.diabetes. | 136 |
| abstract_inverted_index.fantastic | 89 |
| abstract_inverted_index.resulting | 29 |
| abstract_inverted_index.secondary | 85 |
| abstract_inverted_index.treatment | 38, 134 |
| abstract_inverted_index.viewpoint | 124 |
| abstract_inverted_index.autoimmune | 8 |
| abstract_inverted_index.clinically | 80 |
| abstract_inverted_index.effective. | 81 |
| abstract_inverted_index.injection, | 42 |
| abstract_inverted_index.pancreatic | 25 |
| abstract_inverted_index.scientific | 123 |
| abstract_inverted_index.therapies, | 71 |
| abstract_inverted_index.application | 127 |
| abstract_inverted_index.combination | 57 |
| abstract_inverted_index.derivatives | 103 |
| abstract_inverted_index.medications | 93, 112, 131 |
| abstract_inverted_index.metabolites | 86 |
| abstract_inverted_index.replacement | 54 |
| abstract_inverted_index.significant | 50 |
| abstract_inverted_index.traditional | 129 |
| abstract_inverted_index.advancements | 68 |
| abstract_inverted_index.prescription | 111 |
| abstract_inverted_index.anti-diabetic | 70 |
| abstract_inverted_index.autoimmunity, | 28 |
| abstract_inverted_index.characterized | 20 |
| abstract_inverted_index.Immunotherapy, | 53 |
| abstract_inverted_index.complications. | 35 |
| abstract_inverted_index.hyperglycemia, | 33 |
| abstract_inverted_index.insufficiency, | 32 |
| cited_by_percentile_year | |
| corresponding_author_ids | https://openalex.org/A5044324691 |
| countries_distinct_count | 2 |
| institutions_distinct_count | 4 |
| corresponding_institution_ids | https://openalex.org/I16076960 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8700000047683716 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile |